InflaRx Competitors and Similar CompaniesClear all
InflaRx's competitors and similar companies include Grifols and CorMedix.
 InflaRx InflaRx is a biopharmaceutical company developing new therapeutics in the field of acute and chronic inflammation. |  CorMedix CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. | ||
Founding Date | Founding Date 2006 | Founding Date 1909 | Founding Date 2006 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Jena, DE HQ Planegg, DE | Locations Sant Cugat del Vallès, ES HQ Buenos Aires, AR Clayton South, AU São Paulo, BR Mississauga, CA Las Condes, CL see more | Locations Berkeley Heights, US HQ |
Employees | Employees 74 | Employees 23,800 | Employees 3036% increase |
Valuation ($) | Valuation ($) 92.2 m | Valuation ($) 6.7 b | Valuation ($) 749.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) €29k (FY, 2025) | Revenue (est.) €7.5b (FY, 2025) | Revenue (est.) $311.7m (FY, 2025) |
Cost of goods | Cost of goods €7.2m (FY, 2025) | Cost of goods €4.2b (FY, 2025) | Cost of goods $22.1m (FY, 2025) |
Gross profit | Gross profit (€4.5m) (FY, 2025) | Gross profit €3.3b (FY, 2025) | Gross profit $275.7m (FY, 2025) |
Net income | Net income (€45.6m) (FY, 2025) | Net income €500m (FY, 2025) | Net income $163.1m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 89m | Total funding raised N/A | Total funding raised $ 11.5m |
For sources of this data, please see the company profile
View Company Profiles
Grifols
HQ
Sant Cugat del Vallès, ES
Employees
23,800
Grifols is a pharmaceutical and chemical manufacturer.
View companyCorMedix
HQ
Berkeley Heights, US
Employees
30↑ 36% increase
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
View company